Alignment Healthcare's 25x multiple is nothing for a company growing its top line 20%+, with just 1% market share and a better model. @JasperRidley counters that few health insurers trade at 25x EBITDA. x.com 

Clover Health's court win removes the biggest policy overhang on its profitability: on June 1, 2026, a federal court ordered CMS to recalculate Clover's 2026 Medicare Star Rating, which CMS algorithm changes had hurt, risking tens of millions in quality bonuses. Its Counterpart AI drives a flywheel of better predictions, fewer admissions, a lower benefit expense ratio and higher margins, as Q1 showed. At about 0.5x 2026 sales guidance versus 2-5x for peers, a re-rating looks inevitable. x.com